Results presented here showed focal articular surface replacement may be a viable treatment option for focal articular defects in patients younger than 40 years.“Both [biologics and resurfacing] ...

The fracture extends into the trochlear groove ... patient may not completely pass through the epiphysis to the articular surface. Jakob [15] classified this as a type I nondisplaced fracture.